| A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults (NCT05526911) | Global Alliance for TB Drug Development | 2022-06-30 |
| Triage Test for All Oral DR-TB Regimen (TRiAD Study) (NCT05175794) | Centre for the AIDS Programme of Research in South Africa | 2022-05-26 |
| Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial (NCT05017324) | Universiteit Antwerpen | 2021-09-21 |
| A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis (NCT04179500) | Global Alliance for TB Drug Development | 2021-09-16 |
| Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults (NCT04493671) | Global Alliance for TB Drug Development | 2020-06-08 |
| Evaluation of Centralised TB Assay Solutions (NCT04147676) | Foundation for Innovative New Diagnostics, Switzerland | 2019-05-20 |
| Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients (NCT03338621) | Global Alliance for TB Drug Development | 2018-07-30 |
| Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes (NCT04119375) | Massachusetts Institute of Technology | 2018-04-13 |
| An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment (NCT03266003) | Centers for Disease Control and Prevention | 2017-07-19 |
| Brief Bactericidal Activity of Anti-Tuberculosis Drugs (NCT02236078) | Centers for Disease Control and Prevention | 2015-11-01 |
| Rewards for Tuberculosis Contact Screening (NCT02234908) | Boston University | 2014-10-01 |